baminercept (BG 9924) / Biogen 
Welcome,         Profile    Billing    Logout  
 23 Diseases   1 Trial   1 Trial   13 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
baminercept (BG 9924) / Biogen
104UC201: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety, and Tolerability of Baminercept in Subjects With Moderate to Severe Ulcerative Colitis

Active, not recruiting
N/A
100
RoW
baminercept (BG9924, LTβR-Ig)
Biogen Idec
Moderate to Severe Ulcerative Colitis
 
 

Download Options